Professor Shiu-Kum Lam is conferred the first Asian Pacific Digestive Week Federation (APDWF) Meritorious Award at the APDW 2023. This prestigious recognition acknowledges individuals who have made substantial contributions to the consolidation and expansion of the Asian Pacific Digestive Week. The award specifically commends the significant impact an individual has had on fulfilling the objectives and advancing the work of the APDWF, particularly in the organization of high-caliber APDW meetings, one of the largest gathering of Gastroenterologists and Hepatologists.

With numerous publications and global citations, Scholarometer of Google Scholar ranked him the world’s third most cited scholar in gastroenterology 2009-2018. He is a leading figure in gastroenterology, having founded the annual scientific conference, the Asian Pacific Digestive Week together with a group of like-minded physicians.

He has dedicated his career to researching peptic ulcer and gastric cancer, achieving notable milestones such as the first double-blind placebo-controlled study on H. pylori eradication for peptic ulcer cure and the first gastric cancer chemoprevention study in China. His team also discovered that acupuncture produces a shearing acoustic wave, transforming traditional medicine into evidence-based practice. With numerous publications and global citations, he is a leading figure in gastroenterology, having founded the Journal of Gastroenterology and Hepatology and played a key role in internationalizing Chinese gastroenterology conferences. Recognised with prestigious awards, including OBE from Queen of England, Bockus Medal from World Congress of Gastroenterology, Honorary Member British Society of Gastroenterology (<100 in the world), Master of American College of Gastroenterology (only awardee in Asian Pacific at the time), he remains an influential figure in the medical community and continues his mission to combat stomach cancer. In his later career, he invented an endoscopy method for treating gastric intestinal metaplasia, earning patents from Australia and the USA.